Autonomix Medical, Inc.
AMIX
$5.37
$0.101.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -31.35% | -24.84% | -4.93% | 210.89% | 1.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.03% | -15.84% | 21.70% | 165.66% | 24.26% |
| Operating Income | 19.03% | 15.84% | -21.70% | -165.66% | -24.26% |
| Income Before Tax | 18.25% | 16.45% | -20.24% | -165.44% | -23.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.25% | 16.45% | -20.24% | -165.44% | -23.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.25% | 16.45% | -20.24% | -165.44% | -23.64% |
| EBIT | 19.03% | 15.84% | -21.70% | -165.66% | -24.26% |
| EBITDA | 19.05% | 14.67% | -23.67% | -169.87% | -26.13% |
| EPS Basic | 77.89% | 79.76% | 75.14% | 39.46% | 50.94% |
| Normalized Basic EPS | 77.89% | 79.77% | 75.14% | 39.46% | 50.94% |
| EPS Diluted | 77.89% | 79.76% | 75.14% | 39.46% | 50.94% |
| Normalized Diluted EPS | 77.89% | 79.77% | 75.14% | 39.46% | 50.94% |
| Average Basic Shares Outstanding | 269.61% | 312.98% | 383.56% | 338.27% | 151.88% |
| Average Diluted Shares Outstanding | 269.61% | 312.98% | 383.56% | 338.27% | 151.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |